{"id":347815,"date":"2025-05-14T17:30:36","date_gmt":"2025-05-14T12:00:36","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=347815"},"modified":"2025-05-14T17:26:03","modified_gmt":"2025-05-14T11:56:03","slug":"jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/","title":{"rendered":"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences"},"content":{"rendered":"
\n

JSA advised Advent International<\/span> and Suven Pharmaceuticals Limited<\/span>, which is listed in India, in the ~USD 3 billion dollar (combined) merger of Cohance Lifesciences Limited with and into Suven Pharmaceuticals Limited, as one of the largest transactions of its kind.<\/p>\n

Following the merger, Suven Pharmaceuticals Limited has now been renamed as Cohance Lifesciences Limited.<\/p>\n

JSA transaction team was led by Partner & National Corporate Lead, Iqbal Khan<\/span> & Partner, Ambarish<\/span> with support from Principal Associate, Krishaal Morjaria<\/span>, Senior Associate, Tarini Sardesai<\/span> & Associates Ayushi Choudhary<\/span> and Raviraj Zinzuvadia<\/span>.<\/p>\n

Deal value<\/span> — ~USD 3 billion.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger of <\/p>\n","protected":false},"author":67011,"featured_media":347821,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[82049,82051,50808,82050,82048],"class_list":["post-347815","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-international-and-suven-pharmaceuticals","tag-iqbal-khan-partner","tag-jsa","tag-national-corporate-lead","tag-usd"],"yoast_head":"\nJSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences | SCC Times<\/title>\n<meta name=\"description\" content=\"JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences\" \/>\n<meta property=\"og:description\" content=\"JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-14T12:00:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/\",\"name\":\"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp\",\"datePublished\":\"2025-05-14T12:00:36+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp\",\"width\":886,\"height\":590,\"caption\":\"JSA Advises Advent International\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences | SCC Times","description":"JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/","og_locale":"en_US","og_type":"article","og_title":"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences","og_description":"JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-05-14T12:00:36+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.jpeg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/","name":"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp","datePublished":"2025-05-14T12:00:36+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp","width":886,"height":590,"caption":"JSA Advises Advent International"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/14\/jsa-advises-advent-international-and-suven-pharmaceuticals-on-usd-3-billion-merger-with-cohance-lifesciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"JSA Advises Advent International and Suven Pharmaceuticals on USD 3 Billion Merger with Cohance Lifesciences"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-Advises-Advent-International.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":364740,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/25\/sam-co-advises-jusmiral-holdings-350-million-sale-cohance-lifesciences\/","url_meta":{"origin":347815,"position":0},"title":"SAM & Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million ‘On-Market Sale’ of Shares in Cohance Lifesciences Ltd.","author":"Editor","date":"October 25, 2025","format":false,"excerpt":"SAM has earlier advised Advent in its control acquisition of Suven Pharmaceuticals Limited by way of a share purchase and mandatory open offer.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"SAM & Co. advises Jusmiral Holdings","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/SAM-amp-Co.-advises-Jusmiral-Holdings.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":283450,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/02\/08\/khaitan-co-advises-eris-group-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-glenmark-pharmaceuticals-limited\/","url_meta":{"origin":347815,"position":1},"title":"Khaitan & Co. advises Eris Group on its acquisition of a part of the dermatology portfolio of Glenmark Pharmaceuticals Limited","author":"Bhumika Indulia","date":"February 8, 2023","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Brand agreement and supply of agreement between Eris Lifesciences Limited and Glenmark Pharmaceuticals Limited NO HEADINGS DETAILS 1. Sector Pharmaceutical Industry 2. Announcement Date 17-Jan-2023 3. Completion Date 17-Jan-2023 4. Name of Client Eris Lifesciences Limited Eris Lifesciences Ltd is a publicly listed Indian\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/02\/MicrosoftTeams-image-339.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":347377,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/08\/jsa-advises-serum-sale-schott-poonawalla-tpg-scion\/","url_meta":{"origin":347815,"position":2},"title":"JSA Advises Serum Institute on Sale of 35% Stake in Schott Poonawalla to TPG Scion Unit Trust","author":"Editor","date":"May 8, 2025","format":false,"excerpt":"JSA advised Serum Institute of India Private Limited (\u201cSerum\u201d)","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"JSA advises Serum Institute","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-advises-Serum-Institute.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-advises-Serum-Institute.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-advises-Serum-Institute.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/JSA-advises-Serum-Institute.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":369560,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","url_meta":{"origin":347815,"position":3},"title":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion","author":"Editor","date":"December 11, 2025","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Biocon Limited on its ~USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics from multiple investors.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Biocon Biologics integration","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":341417,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/02\/14\/jsa-advises-ongc-ntpc-green-private-limited-for-the-acquisition-of-ayana-renewable-power-private-limited\/","url_meta":{"origin":347815,"position":4},"title":"JSA advises ONGC NTPC Green Private Limited for the acquisition of Ayana Renewable Power Private Limited","author":"Bhumika Indulia","date":"February 14, 2025","format":false,"excerpt":"ONGC NTPC Green Limited (ONGPL) is set to acquire 100% stake in Ayana Renewable Power Private Limited","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Ayana Renewable Power","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/Ayana-Renewable-Power.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/Ayana-Renewable-Power.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/Ayana-Renewable-Power.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/Ayana-Renewable-Power.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":345203,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/04\/04\/jsa-advises-signify-india-on-binding-term-sheet-for-joint-venture-with-dixon-technologies\/","url_meta":{"origin":347815,"position":5},"title":"JSA advises Signify India on Binding Term Sheet for Joint Venture with Dixon Technologies","author":"Bhumika Indulia","date":"April 4, 2025","format":false,"excerpt":"JSA advised Signify Innovations India Limited (Signify India) in connection with the binding term sheet executed by Signify India with Dixon Technologies","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"JSA advises Signify India","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/04\/JSA-advises-Signify-India.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/04\/JSA-advises-Signify-India.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/04\/JSA-advises-Signify-India.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/04\/JSA-advises-Signify-India.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/347815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=347815"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/347815\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/347821"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=347815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=347815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=347815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}